DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic, Indication and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2023" report to their offering.
The global next generation diabetes therapy and drug delivery market was valued at $617 million in 2015, and is estimated to reach $9,673 million by 2023, registering a CAGR of 41.1% from 2016 to 2023.
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. Oral & inhalable insulin painlessly manage the blood glucose level, and is expected to replace the injectable insulins. The use of advanced diabetic systems, such as insulin patches, CGM systems, and artificial pancreas is expected to maintain adherence to medication in diabetic patients and improve the quality of life of diabetic patients.
The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.
- Johnson & Johnson
- Abbott Laboratories
- Medtronic, Inc.
- Novo Nordisk
- MannKind Corporation
- Enteris BioPharma
- Dexcom, Inc.
- Senseonics Holding, Inc.
Key Topics Covered:
CHAPTER 1. INTRODUCTION
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET OVERVIEW
CHAPTER 4. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY PRODUCT TYPE
CHAPTER 5. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY DEMOGRAPHICS
CHAPTER 6. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY INDICATIONS
CHAPTER 7. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY END USERS
CHAPTER 8. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY GEOGRAPHY
CHAPTER 9. COMPANY PROFILES
For more information about this report visit http://www.researchandmarkets.com/research/szktbx/next_generation